MAPT and supranuclear palsy, progressive, 1: Current evidence suggests PSP arises from multifactorial interactions between genetic susceptibility (notably MAPT variants affecting tau metabolism) and environmental influences (e.g., chronic inflammation) (Müller et al., 2025).